Las Vegas, NV -- (SBWIRE) -- 12/05/2013 -- PennyStockEarnings team record for picking gainers is one of the best in the business, and our followers continue to make substantial profits – even in bear markets. Our Team includes top analysts and use level II screeners to get you the information you need to make intelligent decisions for trading penny stocks. Our Today’s Focus is on: Vonage Holdings Corp. (NYSE:VG), VIVUS, Inc. (NASDAQ:VVUS), Dyax Corp. (NASDAQ:DYAX), Education Realty Trust, Inc. (NYSE:EDR)
Vonage Holdings Corp. (NYSE:VG) managed to keep its fall at -0.31% on above-normal volume of 1.44M shares. The stock settled at $3.23 after floating in a range of $3.20 to $3.30. Its latest price has reached market capitalization of $666.03 million. Its 52-week range has been $2.25 to $3.93. Vonage Holdings Corp. (Vonage) is a provider of communications services connecting people through broadband devices worldwide. The Company’s network include session initiation protocol (SIP) based voice over Internet protocol (VoIP), network on the Internet.
Has VG Found The Bottom and Ready To Move Up? Find Out Here
VIVUS, Inc. (NASDAQ:VVUS) traded down on a volume of 1.44 million, lower than its standard daily volume. Shares have dropped-2.66% to $9.88. Over the last twelve months, the stock has lost-12.57% and faced a worst price of $8. VIVUS, Inc. is a biopharmaceutical company. It commercializes and develops therapies to address unmet needs in obesity, sleep apnea, diabetes and sexual health. Its drug, Qsymia (phentermine and topiramate extended-release) was approved by the the United States Food and Drug
Has VVUS Found The Bottom And Ready To Gain Momentum? Find Out Here
Dyax Corp. (NASDAQ:DYAX) settled -1.41% lower at $8.40 on below -normal volume of 1.43M shares during the last trading day. The stock has its 12-month high at $9.29 and 52-week low price was $2.26. It traded in a range of $8.31 to $8.66 during the last trading day. Dyax Corp. (Dyax), is a biopharmaceutical company with two business elements: Angioedema Franchise and Phage Display Licensing and Funded Research Program. It is focused on identifying and developing treatments for patients who experience plasma kallikrein (bradykinin) mediated angioedema.
Will DYAX Get Buyers Even After The Recent Rally? Find Out Here
In the last trading session, Education Realty Trust, Inc. (NYSE:EDR) was up on high volume, trading at a volume of 1.42M shares versus its average daily volume of 1.13 million shares. At $8.78, the stock has attained market capitalization of $1.01 billion. Education Realty Trust, Inc. (the Trust) is a self-managed and self-advised real estate investment trust (REIT). The Company develops, acquires, owns and manages collegiate housing communities located near university campuses. As of December 31, 2012, it owned 43 collegiate housing communities located in 22 states containing 25,003 beds in 8,494 apartment units on or near 38 university campuses.
Will EDR Continue To Move Higher? Find Out Here
PennyStockEarnings.com is keen to discover penny stocks with the potential to make short and long-term gains.
PSE Team record for picking gainers is one of the best in the business, and our followers continue to make substantial profits – even in bear markets. Our Team includes top analysts and use level II screeners to get you the information you need to make intelligent decisions for trading penny stocks.
PLEASE NOTE WELL: The employees of PennyStockEarnings.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockEarnings.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockEarnings.com is not offering securities for sale. Neither PennyStockEarnings.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockEarnings.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockEarnings.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer Here: http://www.pennystockearnings.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)